<DOC>
	<DOC>NCT01871701</DOC>
	<brief_summary>To evaluate the corrected QT interval change(automatic-reading) after single oral administration of escitalopram, quetiapine and moxifloxacin versus placebo in healthy Korean Adults.</brief_summary>
	<brief_title>Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs</brief_title>
	<detailed_description>Randomized, Open-label, Placebo-controlled, 4-way crossover study</detailed_description>
	<mesh_term>Psychotropic Drugs</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>1. Healthy subjects aged 20 40 years. 2. A body weight in the range of 50 kg (inclusive) 90 kg (inclusive) and a body mass index (BMI) in the range 19.0 kg/m2 (inclusive) 25.0 kg/m2 (inclusive). 3. Sufficient ability to understand the nature of the study and any hazards of participating in it. Provide written informed consent after being fully. informed about the study procedures. 1. Presence or history of hypersensitivity or allergic reactions to drugs including investigational product (Escitalopram, Quetiapine, Moxifloxacin)) or other quinolone group antibiotics. 2. Subject judged not eligible for study participation by investigator.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Corrected QT interval prolongation</keyword>
	<keyword>Psychotropic drugs</keyword>
</DOC>